List of works by Kathy D. Miller

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.

scientific article published on 15 March 2017

A brief intervention to minimize psychosexual morbidity in dyads coping with breast cancer

scientific article published in March 2012

A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer

scientific article published in May 2005

A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors

scientific article published on 10 July 2012

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer ⬇️

scientific article (publication date: October 2003)

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

scientific article published on 02 August 2018

A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer

scientific article

A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109

scientific article published on 28 June 2013

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007

scientific article published on 26 September 2014

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

scientific article published on 13 February 2009

A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine

scientific article

A physiologic imaging pilot study of breast cancer treated with AZD2171.

scientific article published on January 2006

A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer

scientific article published in March 2004

Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial

scientific article published on 20 September 2019

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial

scientific article published on 12 January 2018

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells.

scientific article

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial

scientific article published on 01 November 2020

An Effective Epigenetic-PARP inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA-mutations.

scientific article published on 3 April 2018

Angiogenesis and antiangiogenic therapy.

scientific article

Angiogenesis as targeted breast cancer therapy

scientific article published on 17 August 2007

Angiogenesis of breast cancer

scientific article

Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2

scientific article

Antiangiogenic agents in breast cancer

scientific article published on October 2007

Are There Differences in Treatment and Survival Between Poor, Older Black and White Women with Breast Cancer?

scientific article

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

scientific article (publication date: 15 August 2007)

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 01 December 2018

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial

scientific article published on 09 July 2020

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment

scientific article published on 01 July 2019

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

scientific article published on October 2008

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.

scientific article

Breast Cancer in a Wife: How Husbands Cope and How Well It Works

academic journal article

Breast cancer: the role of angiogenesis and antiangiogenic therapy

scientific article published in October 2004

Can tumor angiogenesis be inhibited without resistance?

scientific article

Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.

scientific article published on 5 November 2015

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans

scientific article published on 09 October 2016

Clinical-translational approaches to the Nm23-H1 metastasis suppressor

scientific article published on August 2008

Cognitive appraisals, coping and depressive symptoms in breast cancer patients

scientific article

Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide

scientific article published on January 2004

Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening

scientific article published on 01 February 2020

Comparison of computational algorithms for the classification of liver cancer using SELDI mass spectrometry: a case study

scientific article

Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains

scientific article

Cytochrome P450 polymorphisms and their relationship with premature ovarian failure in premenopausal women with breast cancer receiving doxorubicin and cyclophosphamide

scientific article published on 09 August 2011

Depression in husbands of breast cancer patients: relationships to coping and social support

scientific article published on 10 March 2010

Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.

scientific article published on 25 June 2009

Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype

scientific article published on 13 January 2009

Development of new targeted therapies for breast cancer

scientific article published in January 2008

Development of new targeted therapies for breast cancer.

scientific article published on January 2008

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?

scientific article

Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103)

scientific article published in September 2018

Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast

scientific article published on 16 April 2019

Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer

scientific article published on 3 July 2010

Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.

scientific article published on 4 October 2013

E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer

scientific article published on 01 February 2003

E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.

scientific article published on 11 January 2018

Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer

scientific article published on June 2015

Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer

scientific article published on 22 May 2008

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer

scientific article published on 26 January 2018

EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.

scientific article

Evaluating the Clinical Utility of Circulating Tumor Cells in Metastatic Breast Cancer-Is Not Worse Good Enough?

scientific article published on 05 November 2020

Facile radiosynthesis of new carbon-11-labeled propanamide derivatives as selective androgen receptor modulator (SARM) radioligands for prostate cancer imaging.

scientific article published on 17 August 2011

Facile synthesis of carbon-11-labeled cholesterol-based cationic lipids as new potential PET probes for imaging of gene delivery in cancer

scientific article published on 6 May 2010

Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.

scientific article

Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure

scientific article published on 19 December 2016

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer

scientific article

Health-related quality of life of african american breast cancer survivors compared with healthy African American women

scientific article published in September 2012

Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103

scientific article published on 21 August 2017

Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer

scientific article published on 11 January 2011

Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancer

scientific article published on 02 December 2020

Impact of primary breast cancer therapy on energetic capacity and body composition

article

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice

scientific article published on 04 June 2020

Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer

scientific article published on December 2008

Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer

scientific article

Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer.

scientific article published in December 2003

Issues and challenges for antiangiogenic therapies

scientific article

Metastatic breast cancer patients' expectations and priorities for symptom improvement

scientific article published on 07 May 2018

Monitoring the Longitudinal Intra-tumor Physiological Impulse Response to VEGFR2 Blockade in Breast Tumors Using DCE-CT ⬇️

scientific article published on December 1, 2011

NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4

scientific article published on 09 April 2003

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

scientific article

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off

scientific article published on 02 May 2019

Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment

scientific article

Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer

scientific article published on 13 September 2006

Phase I trial of metronomic oral vinorelbine in patients with advanced cancer

scientific article published on 4 March 2011

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

scientific article

Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.

scientific article

Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer

scientific article

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells

scientific article published on 04 January 2019

Predicting fear of breast cancer recurrence and self-efficacy in survivors by age at diagnosis

scientific article published on May 2012

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue

scientific article published on 13 October 2006

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers

scientific article published on 05 August 2019

Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial

scientific article

Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancer

scientific article published on 07 October 2020

Questioning Our APHINITY for More

scientific article published on 05 June 2017

Radiosynthesis of [11C]Vandetanib and [11C]chloro-Vandetanib as new potential PET agents for imaging of VEGFR in cancer.

scientific article published on 20 April 2011

Radiosynthesis of carbon-11-labeled camptothecin derivatives as potential positron emission tomography tracers for imaging of topoisomerase I in cancers

scientific article published in September 2005

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer

scientific article published on 20 February 2017

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results

scientific article published on 17 April 2018

Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors

scientific article published on 17 May 2016

Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory

scientific article published in January 2005

Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal a

scientific article published on 06 May 2013

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

scientific article

Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial

scientific article published on 04 April 2018

Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?

scientific article

Redefining the target again: chemotherapeutics as vascular disrupting agents?

scientific article published in September 2008

Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and Caregivers

scientific article published on 01 November 2020

Resistance in the anti-angiogenic era: nay-saying or a word of caution?

scientific article

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

scientific article published on October 2006

Role of RPL39 in Metaplastic Breast Cancer.

scientific article published on 31 December 2016

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study

scientific article published on 26 October 2018

Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer

scientific article published on 13 March 2020

Simple synthesis of carbon-11 labeled styryl dyes as new potential PET RNA-specific, living cell imaging probes

scientific article published on 7 March 2008

Simple synthesis of carbon-11-labeled chromen-4-one derivatives as new potential PET agents for imaging of DNA-dependent protein kinase (DNA-PK) in cancer.

scientific article published on 27 April 2012

Survival benefit needed to undergo chemotherapy: Patient and physician preferences.

scientific article published on 21 March 2017

Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years

scientific article published on 12 October 2012

Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100).

scientific article published on 27 August 2011

Symptom experiences in metastatic breast cancer patients: relationships to activity engagement, value-based living, and psychological inflexibility

scientific article published on 20 September 2016

Synthesis and in vitro biological evaluation of carbon-11-labeled quinoline derivatives as new candidate PET radioligands for cannabinoid CB2 receptor imaging

scientific article

Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.

scientific article published in October 2002

Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer

scientific article published on 11 January 2008

Synthesis and preliminary in vitro biological evaluation of new carbon-11-labeled celecoxib derivatives as candidate PET tracers for imaging of COX-2 expression in cancer

scientific article published on 20 May 2011

Synthesis of (Z)-2-((1H-indazol-3-yl)methylene)-6-[¹¹C]methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one as a new potential PET probe for imaging of the enzyme PIM1.

scientific article published on 6 June 2013

Synthesis of 2,6-difluoro-N-(3-[11C]methoxy-1H-pyrazolo[3,4-b]pyridine-5-yl)-3-(propylsulfonamidio)benzamide as a new potential PET agent for imaging of B-Raf(V600E) in cancers

scientific article published on 20 December 2012

Synthesis of 2-[11C]methoxy-3,17β-O,O-bis(sulfamoyl)estradiol as a new potential PET agent for imaging of steroid sulfatase (STS) in cancers

scientific article published on 19 April 2012

Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase

scientific article published on 11 May 2006

Synthesis of [18F]SU11248, a new potential PET tracer for imaging cancer tyrosine kinase

scientific article published in October 2005

Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancers

scientific article published in November 2004

Synthesis of [¹¹C]PBR06 and [¹⁸F]PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO).

scientific article published on 3 July 2011

Synthesis of carbon-11 labeled biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues as new potential PET glioma tumor imaging agents

scientific article published on 31 May 2007

Synthesis of carbon-11 labeled celecoxib derivatives as new candidate PET radioligands for imaging of inflammation

scientific article published on 3 August 2009

Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agents.

scientific article

Synthesis of carbon-11 labeled sulfonanilide analogues as new potential PET agents for imaging of aromatase in breast cancer

scientific article published on 26 October 2006

Synthesis of carbon-11-labeled 4-aryl-4H-chromens as new PET agents for imaging of apoptosis in cancer

scientific article published on 26 September 2009

Synthesis of carbon-11-labeled casimiroin analogues as new potential PET agents for imaging of quinone reductase 2 and aromatase expression in breast cancer

scientific article published on 15 June 2010

Synthesis of carbon-11-labeled tariquidar derivatives as new PET agents for imaging of breast cancer resistance protein (ABCG2)

scientific article published on 13 February 2010

Synthesis of carbon-11-labeled tricyclic necroptosis inhibitors as new potential PET agents for imaging of tumor necrosis factor alpha (TNF-alpha)

scientific article published on 05 May 2010

Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors

scientific article published on 19 November 2007

Synthesis of new carbon-11 labeled naphthalene-sulfonamides for PET imaging of human CCR8

scientific article published on 20 March 2008

Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents

scientific article

Synthesis of radiolabeled protein disulfide isomerase (PDI) inhibitors as new potential PET agents for imaging of the enzyme PDI in neurological disorders and cancer

scientific article

Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers

scientific article published on 06 September 2006

Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester ⬇️

scientific article published on October 1, 2003

Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analogues.

scientific article

TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.

scientific article published on 10 July 2015

Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer

scientific article published on 01 May 2006

The first design and synthesis of [11C]MKC-1 ([11C]Ro 31-7453), a new potential PET cancer imaging agent

scientific article published on October 2010

The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).

scientific article published on 11 November 2010

The implementation of an oncologist referred, exercise self-management program for older breast cancer survivors.

scientific article published in October 2006

The implications of insurance status on presentation, surgical management, and mortality among nonmetastatic breast cancer patients in Indiana

scientific article published on 28 August 2018

The potential and suitability of 2-methoxyestradiol in cancer therapy

scientific article published in August 2005

The role of ErbB inhibitors in trastuzumab resistance

scientific article published on January 2004

The role of vascular endothelial growth factor genetic variability in cancer

scientific article published on 25 August 2009

Triple Negative Breast Cancer—Review of Current and Emerging Therapeutic Strategies

scientific article published in 2016

Using a Neoadjuvant Approach for Evaluating Novel Therapies for Patients With Breast Cancer

scientific article published on 01 May 2018

What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience?

scientific article

[11C]Choline as a potential PET marker for imaging of breast cancer athymic mice

scientific article published in November 2002

[11C]GSK2126458 and [18F]GSK2126458, the first radiosynthesis of new potential PET agents for imaging of PI3K and mTOR in cancers

scientific article

[11C]enzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C

scientific article published on 31 January 2011

Paulina is supported by:

About Paulina

Help